Biomarkers in the Evaluation of Patients Undergoing Chemotherapy with Anthracyclines
- PMID: 38451618
- PMCID: PMC11098577
- DOI: 10.36660/abc.20230821
Biomarkers in the Evaluation of Patients Undergoing Chemotherapy with Anthracyclines
Similar articles
-
Renin-Angiotensin System Inhibition and Beta Blockade Adrenergic May Be Useful to Attenuate Cardiotoxicity by Anthracyclines.Arq Bras Cardiol. 2023 May;120(5):e20230280. doi: 10.36660/abc.20230280. Arq Bras Cardiol. 2023. PMID: 37341298 Free PMC article. English, Portuguese. No abstract available.
-
New advances in medical imaging technology for the evaluation of anthracycline-induced cardiotoxicity.Chin Med J (Engl). 2022 Aug 5;135(15):1883-1885. doi: 10.1097/CM9.0000000000002123. Chin Med J (Engl). 2022. PMID: 36195994 Free PMC article. No abstract available.
-
Acute cardiotoxicity of anthracyclines: Revisiting an old concept in the modern era of oncohaematology.Arch Cardiovasc Dis. 2024 Apr;117(4):297-300. doi: 10.1016/j.acvd.2024.02.003. Epub 2024 Mar 5. Arch Cardiovasc Dis. 2024. PMID: 38494401 No abstract available.
-
Anthracyclines: biosynthesis, engineering and clinical applications.Nat Prod Rep. 2022 Apr 20;39(4):814-841. doi: 10.1039/d1np00059d. Nat Prod Rep. 2022. PMID: 34951423 Review.
-
Expanding the scope of aromatic polyketides by combinatorial biosynthesis.Comb Chem High Throughput Screen. 2003 Sep;6(6):501-12. doi: 10.2174/138620703106298680. Comb Chem High Throughput Screen. 2003. PMID: 14529376 Review.
References
-
- Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63(25PtA):2751–2768. doi: 10.1016/j.jacc.2014.01.073. - DOI - PubMed
-
- Lyon AR, Fernández TL, Couch LS, Asteggiano R, Aznar MC, Klein JB, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-OncologySociety(IC-OS) Eur Heart J. 2022;43(41):4229–4361. doi: 10.1093/eurheartj/ehac244. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources